Global Osteoporosis Drugs Market to Grow at 5.1% During 2022-2027, Spurred by Development of Enhanced Drugs

February 23, 2021

According to the latest report by IMARC Group, titled "Osteoporosis Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the global osteoporosis drugs market reached a value of US$ 15.1 Billion in 2021. Osteoporosis refers to a medical condition that weakens the bone tissues, rendering them brittle and prone to sudden and unexpected fractures. Characterized by lower bone mass, it can cause deterioration of strength in the hip, spine or wrist. It can be diagnosed with the help of X-ray scans, computed tomography (CT) and magnetic resonance imaging (MRI). Upon detection, various drugs are prescribed to the patient that assist in repairing microscopic defects in bones and minimizing the risk of fractures. These medicines can also be used to restore the balance of resorption and formation, thereby enhancing the overall muscle strength in patients.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Global Osteoporosis Drugs Market Trends:

The global market is majorly driven by the rising prevalence of osteoporosis among the masses. This can be accredited to the increasing consumption of tobacco and alcohol and the lack of physical activities among individuals. The increasing incidences of rheumatoid arthritis and menopause among the female population act as a contributing factor to the escalating number of cases of osteoporosis across the globe. Moreover, there has been a considerable rise in the geriatric population that is more susceptible to developing bone-related disorders, which is creating a positive outlook for the market. This is also supported by the growing awareness among the masses regarding the availability of cost-efficient treatment plans across the healthcare sector. Furthermore, extensive research and development (R&D) activities conducted by players have led to the development of drugs that offer enhanced efficacy. There has also been a rise in the number of pipeline drugs in clinical trials with a high probability of approval in the near future. Coupled with the increasing healthcare expenditure, this is anticipated to create a positive outlook for the market. On account of the aforementioned factors, the market is expected to grow at a CAGR of 5.1% during 2022-2027.

Market Summary:

  • On the basis of the product type, the market is divided into bisphosphonates, calcitonin, rank ligand inhibitor, parathyroid hormone therapy (PTH), selective estrogen receptor modulators (SERMS), sclerostin inhibitor, and others.
  • Based on the route of administration, the market has been classified into oral, injectable and others.
  • On the geographical front, the market has been segregated into North America (the United States and Canada), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia and others), Latin America (Brazil, Mexico and others), and Middle East and Africa.
  • The competitive landscape of the market has been studied in the report with the detailed profiles of the key players. Some of these players include Amgen Inc., Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Radius Health Inc., Teva Pharmaceutical Industries Ltd., and UCB S.A.


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Global Osteoporosis Drugs Market to Grow at 5.1% During 2022-2027, Spurred by Development of Enhanced Drugs
Select Licence Type



Benefits of Customization

Personalize This Research

Triangulate with your Data

Get Data as per your Format and Definition

Gain a Deeper Dive into a Specific Application, Geography, Customer or Competitor

Any level of Personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Bayer AH

It was indeed a great experience to work with IMARC on the assignment on Aqua market. The team had done a fantastic job in terms of what was expected, what was assured and what was the result… the report gave us many insights and market know how which allowed us to work on our strength and define exact strategies…

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More